Gore-BioA Fistula Plug to Treat Transsphincteric Fistulas
- Conditions
- Anal FistulaFecal IncontinenceSurgery
- Registration Number
- NCT01584752
- Lead Sponsor
- Central Finland Hospital District
- Brief Summary
This is a prospective clinical study on the efficacy of Gore-BioA fistula plug in high transsphincteric fistulas. Follow-up time is six months
- Detailed Description
Inclusion criteria for the study is a patient with ultrasound or MRI proven high transsphincteric perianal fistula. Patients with Crohns disease, immunosuppressive medication, anovaginal fistula, radiation therapy or chemotherapy are excluded. A Seton is placed in the fistula track for two months before the application of the plug. Patients are followed up for six months. Symptoms of fecal incontinence before and after intervention are monitored with the Cleveland clinic incontinence score.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 60
- Age 18-70 years, male or female
- High cryptoglandular perianal fistula
- Written approval for the study
- Sufficient co-operation for the study
- Localization of the fistula by ultrasound or MRI
- Crohns disease
- Immunosuppressive treatment
- Anovaginal fistula
- Radiation therapy 6 months before study
- Chemotherapy 6 months before study
- Low- or intersphincteric fistula
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Healing of the fistula 6 months
- Secondary Outcome Measures
Name Time Method Symptoms of fecal incontinence 6 months
Trial Locations
- Locations (4)
Helsinki University Hospital
🇫🇮Helsinki, Finland
Central Hospital
🇫🇮Seinäjoki, Finland
Oulu University Hospital
🇫🇮Oulu, Finland
Turku University Hospital
🇫🇮Turku, Finland
Helsinki University Hospital🇫🇮Helsinki, Finland